Clinical and Therapeutic Implications of Follistatin in Solid Tumours.

@article{Shi2016ClinicalAT,
  title={Clinical and Therapeutic Implications of Follistatin in Solid Tumours.},
  author={Lei Shi and Jeyna Resaul and Sioned Owen and Lin Ye and Wen Jiang},
  journal={Cancer genomics & proteomics},
  year={2016},
  volume={13 6},
  pages={425-435}
}
Follistatin (FST), as a single-chain glycosylated protein, has two major isoforms, FST288 and FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for less than 5% of the encoded mRNA. FST is differentially expressed in human tissues and aberrant expression has been observed in a variety of solid tumours, including gonadal, gastric and lung cancer, hepatocellular carcinoma, basal cell carcinoma and melanoma. Based on the current evidence, FST is an antagonist of… CONTINUE READING
16 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…